Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Operating Activities
Net income	$ 5,207	$ 9,161	$ 17,846	$ 26,451
Adjustments to reconcile net income to net cash provided (used) by operating activities
Deferred income taxes			(1,888)	857
Provision for credit losses	1,661	0	6,150	550
Depreciation and amortization			6,456	6,378
Amortization and accretion of premiums/discounts on investment securities			1,301	1,652
Amortization of operating lease right-of-use assets			(60)	(372)
Share-based compensation expense			1,202	1,192
Originations on loans held for sale			(233,656)	(239,004)
Proceeds on loans held for sale			(238,113)	(238,028)
(Increase) in value of bank-owned life insurance			(622)	(653)
Realized loss (gain) on sale of premises and equipment			(476)	0
Realized loss (gain) on derivative instruments			421	(322)
Realized loss (gain) on loans sold			(6,545)	(5,922)
Realized loss (gain) on sale of foreclosed assets			(1)	(27)
Realized loss (gain) on BOLI mortality			0	(1,196)
Realized loss (gain) on servicing rights			(149)	(28)
Net change in:
Accrued interest receivable			(769)	(2,692)
Other assets			127	(3,967)
Accrued expenses and other liabilities			(8,129)	3,879
Net cash provided (used) by operating activities			19,441	24,804
Investing Activities
Proceeds from sales of trading investment securities			8,684	0
Purchases of trading investment securities			(11,220)	0
Proceeds from maturities of investment securities available-for-sale			35,011	52,624
Proceeds from calls of investment securities held-to-maturity			611	242
Proceeds from maturities and paydowns of investment securities held-to-maturity			16,180	17,188
Net (increase) decrease in loans			(275,760)	(162,322)
Net (increase) decrease in FHLB stock			2,809	(5,953)
Purchases of BOLI			(1,935)	0
Proceeds from BOLI mortality claim			0	2,828
Proceeds from sale of premises and equipment			2,799	0
Purchases of premises and equipment			(7,331)	(1,474)
Proceeds from sales of foreclosed assets			37	51
Net cash provided (used) by investing activities			(230,115)	(96,816)
Financing Activities
Net increase (decrease) in deposits			227,939	(43,300)
Net increase (decrease) in short-term borrowings			(69,470)	137,390
Cash dividends paid on common stock			(11,481)	(11,040)
Repurchase of common stock			(232)	(4,556)
Net cash provided (used) by financing activities			146,756	78,494
Net change in cash and cash equivalents			(63,918)	6,482
Cash and cash equivalents at beginning of period			129,893	58,242	$ 58,242
Cash and cash equivalents at end of period	65,975	64,724	65,975	64,724	129,893
Supplemental Cash Flow Disclosures
Interest paid			84,700	50,969
Income taxes paid			260	6,637
Cash dividends declared, not paid			3,963	3,838
Supplemental Disclosures of Noncash Investing and Financing Activities
Loan collateral transferred to foreclosed assets			(5)	(3)
Loan collateral transferred to foreclosed assets			5	3
Premises and equipment transferred to other assets			2,086	0
Right-of-use assets obtained in exchange for new operating lease liabilities, net	$ 5,136	$ 1,240	5,244	1,938	$ 1,938
Change in fair value hedges presented within residential real estate loans and other assets			$ 98	$ 716